Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome
- PMID: 29722332
- PMCID: PMC5956763
- DOI: 10.4103/0366-6999.231520
Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome
Conflict of interest statement
There are no conflicts of interest
Similar articles
-
Supportive pharmacotherapy for patients with acute respiratory distress syndrome.Acta Anaesthesiol Scand Suppl. 1996;109:65-9. Acta Anaesthesiol Scand Suppl. 1996. PMID: 8901950 No abstract available.
-
[Adjunctive pharmacotherapy for acute respiratory distress syndrome].Dtsch Med Wochenschr. 2017 Jan;142(2):96-101. doi: 10.1055/s-0042-105943. Epub 2017 Jan 23. Dtsch Med Wochenschr. 2017. PMID: 28114714 Review. German.
-
Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?Crit Care Clin. 2011 Jul;27(3):561-87. doi: 10.1016/j.ccc.2011.05.001. Crit Care Clin. 2011. PMID: 21742217 Review.
-
Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy.Biol Neonate. 2000 May;77 Suppl 1:2-8. doi: 10.1159/000047050. Biol Neonate. 2000. PMID: 10828579 Review.
-
Surfactant therapy in acute respiratory distress syndrome.Biol Neonate. 1998 Sep;74 Suppl 1:15-20. doi: 10.1159/000047030. Biol Neonate. 1998. PMID: 9730587 Review. No abstract available.
Cited by
-
Inhibition of cathepsin L ameliorates inflammation through the A20/NF-κB pathway in endotoxin-induced acute lung injury.iScience. 2024 Oct 4;27(11):111024. doi: 10.1016/j.isci.2024.111024. eCollection 2024 Nov 15. iScience. 2024. PMID: 39559762 Free PMC article.
-
Elsholtzia bodinieri Vaniot Ameliorated Acute Lung Injury by NQO1, BCL2 and PTGS2 In Silico and In Vitro Analyses.Int J Mol Sci. 2022 Dec 9;23(24):15651. doi: 10.3390/ijms232415651. Int J Mol Sci. 2022. PMID: 36555290 Free PMC article.
-
Huangkui Capsule Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Macrophage Activation by Suppressing Inflammation and Oxidative Stress in Mice.Evid Based Complement Alternat Med. 2021 Sep 22;2021:6626483. doi: 10.1155/2021/6626483. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 35528830 Free PMC article.
-
lincRNA-Cox2 Functions to Regulate Inflammation in Alveolar Macrophages during Acute Lung Injury.J Immunol. 2022 Apr 15;208(8):1886-1900. doi: 10.4049/jimmunol.2100743. Epub 2022 Apr 1. J Immunol. 2022. PMID: 35365562 Free PMC article.
-
N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review study.J Res Med Sci. 2020 Nov 26;25:109. doi: 10.4103/jrms.JRMS_777_20. eCollection 2020. J Res Med Sci. 2020. PMID: 33824674 Free PMC article. Review.
References
-
- Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in Intensive Care Units in 50 countries. JAMA. 2016;315:788–800. doi: 10.1001/jama.2016.0291. - PubMed
-
- Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377:562–72. doi: 10.1056/NEJMc1711824. - PubMed
-
- ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012;307:2526–33. doi: 10.1001/jama.2012.5669. - PubMed
-
- Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al. Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest. 2007;131:954–63. doi: 10.1378/chest.06-2100. - PubMed
-
- Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354:1671–84. doi: 10.1056/NEJMoa051693. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources